ArticleAmerican journal of translational research2020

SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models.

Xiaoling Zhao et al.PubMed ↗Full text ↗

No numbers read from the abstract.